BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1676608)

  • 21. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
    Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome 22 heterozygosity is retained in most hyperdiploid and pseudodiploid meningiomas.
    Bello MJ; de Campos JM; Vaquero J; Kusak ME; Sarasa JL; Rey JA; Pestaña A
    Cancer Genet Cytogenet; 1993 Apr; 66(2):117-9. PubMed ID: 8500098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.
    Ruttledge MH; Sarrazin J; Rangaratnam S; Phelan CM; Twist E; Merel P; Delattre O; Thomas G; Nordenskjöld M; Collins VP
    Nat Genet; 1994 Feb; 6(2):180-4. PubMed ID: 8162072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
    Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
    Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.
    Maxwell M; Shih SD; Galanopoulos T; Hedley-Whyte ET; Cosgrove GR
    J Neurosurg; 1998 Mar; 88(3):562-9. PubMed ID: 9488313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.
    Wolff RK; Frazer KA; Jackler RK; Lanser MJ; Pitts LH; Cox DR
    Am J Hum Genet; 1992 Sep; 51(3):478-85. PubMed ID: 1496981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus.
    Pergolizzi RG; Erster SH
    Mol Chem Neuropathol; 1994; 21(2-3):189-217. PubMed ID: 7916188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics of meningiomas.
    Ragel BT; Jensen RL
    Neurosurg Focus; 2005 Nov; 19(5):E9. PubMed ID: 16398473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity on chromosome 3, bands q24----qter, in a diploid meningioma.
    Färber U; Schneider G; Schrell UM; Fahlbusch P; Adams EF; Blin N; Henn W
    Cytogenet Cell Genet; 1991; 57(2-3):157-8. PubMed ID: 1680607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular genetics of meningiomas.
    Collins VP; Nordenskjöld M; Dumanski JP
    Brain Pathol; 1990 Sep; 1(1):19-24. PubMed ID: 1688296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal instability in meningiomas.
    van Tilborg AA; Al Allak B; Velthuizen SC; de Vries A; Kros JM; Avezaat CJ; de Klein A; Beverloo HB; Zwarthoff EC
    J Neuropathol Exp Neurol; 2005 Apr; 64(4):312-22. PubMed ID: 15835267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity and the origin of meningioma.
    Meese E; Blin N; Zang KD
    Hum Genet; 1987 Dec; 77(4):349-51. PubMed ID: 2891603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene.
    Peyrard M; Fransson I; Xie YG; Han FY; Ruttledge MH; Swahn S; Collins JE; Dunham I; Collins VP; Dumanski JP
    Hum Mol Genet; 1994 Aug; 3(8):1393-9. PubMed ID: 7987321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms.
    Heinrich B; Hartmann C; Stemmer-Rachamimov AO; Louis DN; MacCollin M
    Int J Cancer; 2003 Feb; 103(4):483-8. PubMed ID: 12478663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
    Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
    Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
    von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
    Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas.
    Leuraud P; Marie Y; Robin E; Huguet S; He J; Mokhtari K; Cornu P; Hoang-Xuan K; Sanson M
    J Neurooncol; 2000 Dec; 50(3):207-13. PubMed ID: 11263500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
    Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
    Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.